| ARCHETYPE ID | openEHR-EHR-OBSERVATION.iss.v0 |
|---|---|
| Concept | International Staging System for Multiple Myeloma (ISS) |
| Description | A staging system for classifying and stratifying patients with multiple myeloma. |
| Use | Use to record the results for each component parameter and the resulting ISS stage. |
| Misuse | Not to be used to record the results for the Revised Multiple Myeloma International Staging System (R-ISS) - use the specialisation of this archetype for this purpose. |
| Purpose | To record the results for each component parameter and the resulting ISS stage. |
| References | Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975 Sep;36(3):842-54. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u. PMID: 1182674. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J. International staging system for multiple myeloma. J Clin Oncol. 2005 May 20;23(15):3412-20. doi: 10.1200/JCO.2005.04.242. Epub 2005 Apr 4. Erratum in: J Clin Oncol. 2005 Sep 1;23(25):6281. Harousseau, Jean-Luc [corrected to Avet-Loiseau, Herve]. PMID: 15809451. |
| Copyright | © Cambio CDS, openEHR Foundation |
| Authors | Author name: Maryam Razavi Organisation: Cambio CDS Email: maryam.razavi@cambio.se Date originally authored: 2020-12-22 |
| Other Details Language | Author name: Maryam Razavi Organisation: Cambio CDS Email: maryam.razavi@cambio.se Date originally authored: 2020-12-22 |
| Other Details (Language Independent) |
|
| Keywords | albumin, multiple, myeloma, staging, system |
| Lifecycle | in_development |
| UID | f7f8c6bb-02e3-4045-8673-16e305334509 |
| Language used | en |
| Citeable Identifier | 1246.145.2859 |
| Revision Number | 0.0.1-alpha |
| protocol | |
| Extension | Extension: Additional information required to extend the model with local content or to align with other reference models or formalisms. For example: local information requirements; or additional metadata to align with FHIR. Include: All not explicitly excluded archetypes |
| data | |
| Serum β2 microglobulin | Serum β2 microglobulin:
|
| Serum albumin | Serum albumin:
|
| ISS stage | ISS stage:
|
| events | |
| Any event | Any event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time. |
| Other contributors | |
| Translators |